Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Lehman Upgrades JC Penney


Lehman Brothers upgraded JC Penney (JCP ) to strong buy from buy.

Analyst Jeff Feiner says EBITDA valuation for Eckerd indicates the drug store business is worth more than JC Penney's current overall stock price. Also, he sees an improving competitive position for department stores over the longer term. He raised his $0.30 fiscal 2002 (Jan.) EPS estimate to $0.35, and raised the $0.65 fiscal 2003 to $0.75. He notes CEO Allen Questrom's goal to grow EBIT at both drug and department stores to 4.5% and 6% of sales over the next three to five years, respectively, through merchandising and cost controls. Feiner has a $33 12-month price target ($25 for Eckerd, and a conservative $8 for department stores).


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus